# Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.

> **NCT04491240** · PHASE1,PHASE2 · COMPLETED · sponsor: **State-Financed Health Facility "Samara Regional Medical Center Dinasty"** · enrollment: 30 (actual)

## Conditions studied

- Covid19
- SARS-CoV-2 PNEUMONIA
- COVID-19

## Interventions

- **DRUG:** EXO 1 inhalation
- **DRUG:** EXO 2 inhalation
- **DRUG:** Placebo inhalation

## Key facts

- **NCT ID:** NCT04491240
- **Lead sponsor:** State-Financed Health Facility "Samara Regional Medical Center Dinasty"
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-20
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04491240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04491240, "Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04491240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*